UBS Group’s Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class BFT.WS Stock Holding History
Bought
Maintained
Sold
UBS Group's BFT.WS Position: Q1 2021 in Review
UBS Group sold out of Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class (BFT.WS) in Q1 2021, closing a stake of 1,820 shares — an estimated $8K sold.
UBS Group first reported a position in BFT.WS in Q4 2020 and held it in 1 quarter. The position peaked at $8K in Q4 2020. 0 funds tracked by Wall St. Rank hold BFT.WS as of Q1 2021.
- UBS Group reported no remaining Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class position as of Q1 2021 after selling out during the quarter.
- UBS Group sold 1,820 Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class shares in Q1 2021, an estimated $8K.
- UBS Group first reported a position in Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class in Q4 2020 and held it in 1 quarter.
- UBS Group's Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class position peaked at $8K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Foley Trasimene Acquisition Corp. II Warrants, each whole warrant exercisable for one share of Class as of Q1 2021.
Based on UBS Group's 13F filing for Q1 2021, filed 12 May 2021.